Abstract
Design and development considerations for autoinjector (AI)-based combination products are described from both pharma company and device supplier perspectives. The importance of understanding patient needs and developing design inputs early is highlighted, and the typical feature sets of AIs and general usage steps are explained. Examples of currently marketed autoinjector-based combination products are listed for comparison. An holistic device technology and partner selection process is presented from a pharma company perspective. This process considers device technology as but one aspect that must be assessed, and many other collaboration factors that are critical for ensuring a predictable product development process are highlighted. The concept of platform autoinjectors is defined, and their advantages (relative to bespoke development) are explained in terms of development cost and efficiency. Future challenges of autoinjector design and development are framed relative to delivery of higher volumes of potentially more viscous drug product formulations, with improved usability. AIs with connectivity as an added feature for improved compliance and patient outcomes are just beginning to appear on the market, and this is expected to grow significantly in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heise T, et al. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial. Diabetes Obes Metab. 2014;16(10):971–6.
Berteau C, et al. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Med Devices (Auckl). 2015;8:473.
Dias C, et al. Tolerability of high-volume subcutaneous injections of a viscous placebo buffer: A randomized, crossover study in healthy subjects, AAPS PharmSciTech. 2015 Oct;16(5):1101–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Laurusonis, L., Cleathero, I., Jensen, H.J. (2020). Chapter 33: Design and Development Considerations for Autoinjector Delivery Systems: Technology Developer and Industry Perspectives. In: Jameel, F., Skoug, J., Nesbitt, R. (eds) Development of Biopharmaceutical Drug-Device Products. AAPS Advances in the Pharmaceutical Sciences Series, vol 35. Springer, Cham. https://doi.org/10.1007/978-3-030-31415-6_33
Download citation
DOI: https://doi.org/10.1007/978-3-030-31415-6_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31414-9
Online ISBN: 978-3-030-31415-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)